Related Experiment Video
Updated: Mar 12, 2026

Portable Thermographic Screening for Detection of Acute Wallenberg's Syndrome
Published on: September 19, 2019
Ataxia telangiectasia: presentation and diagnostic delay
Rebecca Devaney1, Sara Pasalodos2, Mohnish Suri2
1Nottingham Children's Hospital, National Paediatric Ataxia Telangiectasia Clinic, QMC, Nottingham, UK.
Insights
Diagnosing Ataxia-Telangiectasia (A-T), a rare genetic disorder, involves significant delays. Earlier identification of A-T symptoms and alpha-fetoprotein (AFP) testing can improve diagnosis times.
Area of Science:
- Genetics
- Neurology
- Pediatrics
Background:
- Ataxia-Telangiectasia (A-T) is a rare, progressive, multisystem genetic disorder.
- Families of children with ultra-rare diseases often face diagnostic delays.
Purpose of the Study:
- To review the diagnostic process for A-T.
- To identify causes of diagnostic delay for earlier A-T identification.
Main Methods:
- Retrospective case note review of 79 children at a National Paediatric A-T clinic.
- Data collected on symptom onset, presentation age, alpha-fetoprotein (AFP) levels, and genetic confirmation age.
Main Results:
- At presentation, 90% of children had ataxia.
- Median presentation delay was 8 months; median diagnostic delay was 12 months.
- Significant delays were observed from initial concern to genetic confirmation.
Conclusions:
- There are significant delays in A-T presentation and diagnosis.
- Increased awareness of A-T and early AFP measurement could improve diagnostic timelines.
Background And Aims:
Ataxia telangiectasia (A-T) is a rare progressive, multisystem genetic disease. Families of children with ultra-rare diseases often experience significant diagnostic delays. We reviewed the diagnostic process for A-T in order to identify causes of delay in an attempt to facilitate earlier identification of A-T in the future.
Methods:
A retrospective case note review of 79 children at the National Paediatric A-T clinic seen since May 2009. Data were collected on the nature and age of initial symptoms, the age at first presentation, measurement of alpha feto-protein (AFP) and age of genetic diagnostic confirmation.
Results:
At presentation, 71 children (90%) had ataxia. The median presentation delay (from first parental concern to presentation) was 8 months (range 0-118 months), and the median diagnostic delay (genetic confirmation of diagnosis) was 12 months (range 1-109 months).
Conclusions:
There are significant delays in presentation and diagnostic confirmation of A-T. A greater awareness of A-T and early measurement of AFP may help to improve this.
Related Concept Videos
Aneurysm II: Clinical Manifestations and Diagnostic Studies
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
Autism Spectrum Disorder
These core symptoms manifest differently among individuals, ranging from mild to severe. The disorder's complexity extends beyond its clinical presentation, encompassing a diverse range of biological, cognitive, and sociocultural influences.
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Acute Coronary Syndrome III: Diagnostic Studies

